Oxygenta Pharmaceutical P/B Ratio
OXYGENTAPH • Price-to-Book ratio analysis and book value breakdown
Current P/B Ratio
-5.54
Low Valuation
Very Low - Significant discount to book value, potential distress or value opportunity
Current Valuation Metrics
P/B Ratio
-5.54
Current Price
₹51.49
Book Value/Share
₹-6.76
Exchange
BSE
Book Value Breakdown (2025)
Balance Sheet Components
Total Equity
₹-25 Cr
Share Capital
₹37 Cr
Reserves & Surplus
₹-62 Cr
Outstanding Shares
37,000,000
Book Value per Share
₹-6.76
Valuation Signal
Signal
Undervalued
Sector Context
Sector Average
-0.02
Sector Median
0.7
Sector Rank
#3 of 50
Sector Percentile
6.0%
Key P/B Ratio Insights for Oxygenta Pharmaceutical
- Stock appears undervalued with PB of -5.54, trading below book value
- Trading below book value - potential value opportunity or financial distress signal
- Trading at discount to sector average PB of -0.02
View the current stock price of Oxygenta Pharmaceutical for more insights.
Related Pages for Oxygenta Pharmaceutical
Additional stock information and data for OXYGENTAPH
Sector P/B Ratio Comparison
Comparing Oxygenta Pharmaceutical with other companies in Healthcare sector
Sector Average
-0.02
Sector Median
0.7
Lowest P/B
-12.71
Highest P/B
1.13
Companies
50
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sun Pharma Advanced Rese… | SPARC | -12.71 | ₹4,287 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.47 | ₹95 | Low |
| Parmax Pharma | PARMAX | -2.15 | ₹12 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.96 | ₹154 | Low |
| Cresanto Global | CRESANTO | -0.67 | ₹2 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |
| Murae Organisor | MURAE | 0.22 | ₹47 | Low |